Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: UNITED BIOPHARMA, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2024-09-30 to 2025-10-28
Current total value of award: $400000
Description: CLINICAL GRADE MONOCLONAL ANTIBODY UB-421 INCLUDES: ONE 100-LITER BATCH OF GMP-MANUFACTURER UB-421, STERILE VIALING, AND LONG-TERM AND ACCELERATED STABILITY STUDIES.